Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126493622 | 12649362 | 2 | F | 20160826 | 20160812 | 20160902 | EXP | AU-MYLANLABS-2016M1033819 | MYLAN | MCFADDEN M, GORDON A, LEONG G, WARD D, SCOTT JG. PANCREATITIS ASSOCIATED WITH METFORMIN USED FOR MANAGEMENT OF CLOZAPINE RELATED WEIGHT GAIN.. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. 2016;50(7):701-2 | 0.00 | Y | 0.00000 | 20160902 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126493622 | 12649362 | 1 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, AM | Y | U | 75973 | 500 | MG | QD | |||||
| 126493622 | 12649362 | 2 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1500 MG, BID | Y | U | 75973 | 1500 | MG | BID | |||||
| 126493622 | 12649362 | 3 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, BID | Y | U | 75973 | 500 | MG | BID | |||||
| 126493622 | 12649362 | 4 | SS | CLOZAPINE. | CLOZAPINE | 1 | U | U | 0 | ||||||||||
| 126493622 | 12649362 | 5 | SS | CLOZAPINE. | CLOZAPINE | 1 | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126493622 | 12649362 | 1 | Weight increased |
| 126493622 | 12649362 | 4 | Schizophrenia |
| 126493622 | 12649362 | 5 | Intellectual disability |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126493622 | 12649362 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126493622 | 12649362 | Nausea | |
| 126493622 | 12649362 | Neutrophilia | |
| 126493622 | 12649362 | Off label use | |
| 126493622 | 12649362 | Pancreatitis relapsing | |
| 126493622 | 12649362 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |